PTK2 and non-small cell lung carcinoma: To establish an in vitro model mimicking FAK inhibitor resistance in NSCLC, we treated A549 cells with increasing doses of VS-4718, which resulted in the enrichment of drug-resistant cells that were characterized by slow proliferation and a mesenchymal-like morphology (Fig. 5A,B).